Pathological features play a key role in the diagnosis of FH-deficient RCC, but more experience is needed with low-grade morphologic tumors, and immunohistochemistry is a useful tool to differentiate this tumor from other renal tumors. The gene discussed is FH; the disease is renal cell carcinoma.